

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | surfactant homeostasis (GO:0043129) | 5.38545338 |
| 2 | intestinal cholesterol absorption (GO:0030299) | 4.47476347 |
| 3 | cysteine metabolic process (GO:0006534) | 4.15616220 |
| 4 | chemical homeostasis within a tissue (GO:0048875) | 4.12331988 |
| 5 | type I interferon signaling pathway (GO:0060337) | 4.03644810 |
| 6 | cellular response to type I interferon (GO:0071357) | 4.03644810 |
| 7 | response to type I interferon (GO:0034340) | 3.96516312 |
| 8 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.86491070 |
| 9 | regulation of interferon-alpha production (GO:0032647) | 3.63480695 |
| 10 | regulation of vitamin metabolic process (GO:0030656) | 3.56713989 |
| 11 | intestinal absorption (GO:0050892) | 3.48873663 |
| 12 | positive regulation of interferon-alpha production (GO:0032727) | 3.46585262 |
| 13 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.43179329 |
| 14 | cellular response to interferon-alpha (GO:0035457) | 3.38006123 |
| 15 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.34612650 |
| 16 | COPI coating of Golgi vesicle (GO:0048205) | 3.25962909 |
| 17 | Golgi transport vesicle coating (GO:0048200) | 3.25962909 |
| 18 | homocysteine metabolic process (GO:0050667) | 3.21838194 |
| 19 | urea metabolic process (GO:0019627) | 3.21026127 |
| 20 | urea cycle (GO:0000050) | 3.21026127 |
| 21 | peptide catabolic process (GO:0043171) | 3.20829638 |
| 22 | NIK/NF-kappaB signaling (GO:0038061) | 3.20180785 |
| 23 | protein carboxylation (GO:0018214) | 3.12877099 |
| 24 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.12877099 |
| 25 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.12087266 |
| 26 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.10095834 |
| 27 | regulation of RIG-I signaling pathway (GO:0039535) | 3.08395189 |
| 28 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.08046447 |
| 29 | sulfur amino acid catabolic process (GO:0000098) | 3.05381574 |
| 30 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.02268129 |
| 31 | protein retention in ER lumen (GO:0006621) | 3.02061431 |
| 32 | response to peptidoglycan (GO:0032494) | 2.99376748 |
| 33 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.98765997 |
| 34 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.91220831 |
| 35 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.87818031 |
| 36 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.85626084 |
| 37 | L-phenylalanine catabolic process (GO:0006559) | 2.85626084 |
| 38 | regulation of podosome assembly (GO:0071801) | 2.84897253 |
| 39 | nitrogen cycle metabolic process (GO:0071941) | 2.83928708 |
| 40 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.83745934 |
| 41 | L-phenylalanine metabolic process (GO:0006558) | 2.83745934 |
| 42 | regulation of cholesterol homeostasis (GO:2000188) | 2.81986809 |
| 43 | hormone catabolic process (GO:0042447) | 2.80515614 |
| 44 | myeloid dendritic cell differentiation (GO:0043011) | 2.78593445 |
| 45 | negative regulation of viral genome replication (GO:0045071) | 2.76618605 |
| 46 | COPII vesicle coating (GO:0048208) | 2.75840850 |
| 47 | alpha-linolenic acid metabolic process (GO:0036109) | 2.75752489 |
| 48 | negative regulation of interleukin-12 production (GO:0032695) | 2.74515251 |
| 49 | pinocytosis (GO:0006907) | 2.74361233 |
| 50 | response to nitrosative stress (GO:0051409) | 2.74274233 |
| 51 | high-density lipoprotein particle remodeling (GO:0034375) | 2.74236284 |
| 52 | negative regulation of fibrinolysis (GO:0051918) | 2.73890338 |
| 53 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.73575032 |
| 54 | low-density lipoprotein particle clearance (GO:0034383) | 2.73264063 |
| 55 | response to interferon-alpha (GO:0035455) | 2.73017799 |
| 56 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.72662829 |
| 57 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.72507939 |
| 58 | regulation of triglyceride catabolic process (GO:0010896) | 2.71869876 |
| 59 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.71623292 |
| 60 | protein localization to endosome (GO:0036010) | 2.71326388 |
| 61 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.70794305 |
| 62 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.70794305 |
| 63 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.70578663 |
| 64 | cellular response to virus (GO:0098586) | 2.69470800 |
| 65 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.69075966 |
| 66 | cholesterol efflux (GO:0033344) | 2.68716563 |
| 67 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.68645241 |
| 68 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.67174331 |
| 69 | mitotic chromosome condensation (GO:0007076) | 2.65282412 |
| 70 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.64284787 |
| 71 | nuclear pore organization (GO:0006999) | 2.62806933 |
| 72 | plasma lipoprotein particle assembly (GO:0034377) | 2.62578740 |
| 73 | regulation of response to interferon-gamma (GO:0060330) | 2.62212640 |
| 74 | T cell migration (GO:0072678) | 2.60990214 |
| 75 | cholesterol transport (GO:0030301) | 2.59369457 |
| 76 | sterol transport (GO:0015918) | 2.59369457 |
| 77 | cellular glucuronidation (GO:0052695) | 2.58908077 |
| 78 | aromatic amino acid family catabolic process (GO:0009074) | 2.58000489 |
| 79 | lipoprotein metabolic process (GO:0042157) | 2.56711991 |
| 80 | negative regulation of sterol transport (GO:0032372) | 2.56159874 |
| 81 | negative regulation of cholesterol transport (GO:0032375) | 2.56159874 |
| 82 | plasma lipoprotein particle clearance (GO:0034381) | 2.56097488 |
| 83 | serine family amino acid metabolic process (GO:0009069) | 2.55957312 |
| 84 | regulation of protein activation cascade (GO:2000257) | 2.54443645 |
| 85 | immunoglobulin mediated immune response (GO:0016064) | 2.54147633 |
| 86 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.53793557 |
| 87 | embryonic process involved in female pregnancy (GO:0060136) | 2.52233739 |
| 88 | reverse cholesterol transport (GO:0043691) | 2.51661458 |
| 89 | response to xenobiotic stimulus (GO:0009410) | 2.51069282 |
| 90 | pore complex assembly (GO:0046931) | 2.50960908 |
| 91 | phospholipid efflux (GO:0033700) | 2.49149032 |
| 92 | hepatocyte apoptotic process (GO:0097284) | 2.48875889 |
| 93 | glycine metabolic process (GO:0006544) | 2.48766268 |
| 94 | 4-hydroxyproline metabolic process (GO:0019471) | 2.48452337 |
| 95 | myeloid dendritic cell activation (GO:0001773) | 2.48039664 |
| 96 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.47718158 |
| 97 | germinal center formation (GO:0002467) | 2.47540066 |
| 98 | bile acid and bile salt transport (GO:0015721) | 2.47424460 |
| 99 | positive regulation of interferon-beta production (GO:0032728) | 2.46243703 |
| 100 | serine family amino acid biosynthetic process (GO:0009070) | 2.46004436 |
| 101 | sterol homeostasis (GO:0055092) | 2.45275856 |
| 102 | cholesterol homeostasis (GO:0042632) | 2.44857613 |
| 103 | regulation of complement activation (GO:0030449) | 2.44819158 |
| 104 | angiotensin maturation (GO:0002003) | 2.43155236 |
| 105 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.42863729 |
| 106 | tryptophan metabolic process (GO:0006568) | 2.41131218 |
| 107 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.40670453 |
| 108 | protein-lipid complex assembly (GO:0065005) | 2.40603554 |
| 109 | B cell proliferation (GO:0042100) | 2.39583010 |
| 110 | amino-acid betaine metabolic process (GO:0006577) | 2.39087778 |
| 111 | modulation by symbiont of host immune response (GO:0052553) | 2.38820250 |
| 112 | positive regulation by symbiont of host defense response (GO:0052509) | 2.38820250 |
| 113 | modulation by symbiont of host defense response (GO:0052031) | 2.38820250 |
| 114 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.38820250 |
| 115 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.38820250 |
| 116 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.38820250 |
| 117 | tetrahydrofolate metabolic process (GO:0046653) | 2.38390678 |
| 118 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.37196420 |
| 119 | fibrinolysis (GO:0042730) | 2.37064520 |
| 120 | macrophage activation involved in immune response (GO:0002281) | 2.36991312 |
| 121 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.36872637 |
| 122 | mesodermal cell differentiation (GO:0048333) | 2.36082170 |
| 123 | indolalkylamine catabolic process (GO:0046218) | 2.35527628 |
| 124 | tryptophan catabolic process (GO:0006569) | 2.35527628 |
| 125 | indole-containing compound catabolic process (GO:0042436) | 2.35527628 |
| 126 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.34554248 |
| 127 | B cell mediated immunity (GO:0019724) | 2.33286673 |
| 128 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.33193997 |
| 129 | cell adhesion mediated by integrin (GO:0033627) | 2.33004215 |
| 130 | regulation of fibrinolysis (GO:0051917) | 2.32474335 |
| 131 | imidazole-containing compound metabolic process (GO:0052803) | 2.31880103 |
| 132 | xenobiotic catabolic process (GO:0042178) | 2.31052738 |
| 133 | glucuronate metabolic process (GO:0019585) | 2.30648393 |
| 134 | uronic acid metabolic process (GO:0006063) | 2.30648393 |
| 135 | protein-lipid complex remodeling (GO:0034368) | 2.30448665 |
| 136 | macromolecular complex remodeling (GO:0034367) | 2.30448665 |
| 137 | plasma lipoprotein particle remodeling (GO:0034369) | 2.30448665 |
| 138 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.30027197 |
| 139 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.29679308 |
| 140 | one-carbon metabolic process (GO:0006730) | 2.28873186 |
| 141 | bile acid metabolic process (GO:0008206) | 2.28282725 |
| 142 | positive regulation of type 2 immune response (GO:0002830) | 2.28063378 |
| 143 | glycosphingolipid catabolic process (GO:0046479) | 2.27517583 |
| 144 | lysine metabolic process (GO:0006553) | 2.27510940 |
| 145 | lysine catabolic process (GO:0006554) | 2.27510940 |
| 146 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.27306333 |
| 147 | complement activation, alternative pathway (GO:0006957) | 2.27074750 |
| 148 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.27057476 |
| 149 | regulation of cholesterol esterification (GO:0010872) | 2.26540055 |
| 150 | serine family amino acid catabolic process (GO:0009071) | 2.26500363 |
| 151 | T cell lineage commitment (GO:0002360) | 2.26273311 |
| 152 | nuclear pore complex assembly (GO:0051292) | 2.25750473 |
| 153 | ethanol oxidation (GO:0006069) | 2.25455301 |
| 154 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.25426764 |
| 155 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.25251755 |
| 156 | regulation of chronic inflammatory response (GO:0002676) | 2.25210828 |
| 157 | phospholipid homeostasis (GO:0055091) | 2.25026250 |
| 158 | bile acid biosynthetic process (GO:0006699) | 2.24959499 |
| 159 | acute-phase response (GO:0006953) | 2.24008538 |
| 160 | positive regulation of humoral immune response (GO:0002922) | 2.23940864 |
| 161 | acylglycerol homeostasis (GO:0055090) | 2.23660138 |
| 162 | triglyceride homeostasis (GO:0070328) | 2.23660138 |
| 163 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 2.22198952 |
| 164 | T-helper 1 type immune response (GO:0042088) | 2.22021147 |
| 165 | negative regulation of defense response to virus (GO:0050687) | 2.21885265 |
| 166 | folic acid metabolic process (GO:0046655) | 2.21332189 |
| 167 | dendritic cell differentiation (GO:0097028) | 2.21136883 |
| 168 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.20723286 |
| 169 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.20274744 |
| 170 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.20111081 |
| 171 | L-ascorbic acid metabolic process (GO:0019852) | 2.19450751 |
| 172 | cellular response to ethanol (GO:0071361) | 2.19296736 |
| 173 | cellular response to interferon-gamma (GO:0071346) | 2.17127746 |
| 174 | oligosaccharide catabolic process (GO:0009313) | 2.16829839 |
| 175 | defense response to virus (GO:0051607) | 2.16717951 |
| 176 | negative regulation of type I interferon production (GO:0032480) | 2.15834712 |
| 177 | DNA unwinding involved in DNA replication (GO:0006268) | 2.14737947 |
| 178 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.13499332 |
| 179 | modulation by symbiont of host cellular process (GO:0044068) | 2.13195313 |
| 180 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.11989953 |
| 181 | detection of other organism (GO:0098543) | 2.11001482 |
| 182 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.10203677 |
| 183 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.10179283 |
| 184 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.09998597 |
| 185 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.09683202 |
| 186 | response to muramyl dipeptide (GO:0032495) | 2.09277104 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.02615239 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.65686334 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.47595429 |
| 4 | GATA1_22025678_ChIP-Seq_K562_Human | 3.15557317 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.11228498 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.05210405 |
| 7 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.96855025 |
| 8 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.91994748 |
| 9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.86537016 |
| 10 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.83273028 |
| 11 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.73317706 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.70182730 |
| 13 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.48424599 |
| 14 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.33726607 |
| 15 | MYC_22102868_ChIP-Seq_BL_Human | 2.22872073 |
| 16 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.21486947 |
| 17 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.15585507 |
| 18 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.10334911 |
| 19 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.03433924 |
| 20 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.95589056 |
| 21 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.93741331 |
| 22 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.89888138 |
| 23 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.89805194 |
| 24 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.87583369 |
| 25 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.80901441 |
| 26 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.77038574 |
| 27 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.70154917 |
| 28 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.66649048 |
| 29 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.64530885 |
| 30 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.62690649 |
| 31 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.62419958 |
| 32 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.61945275 |
| 33 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.60041889 |
| 34 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.55355501 |
| 35 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.55083956 |
| 36 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.54803915 |
| 37 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.52523640 |
| 38 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.51407972 |
| 39 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.48878506 |
| 40 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.48045888 |
| 41 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.45286797 |
| 42 | MAF_26560356_Chip-Seq_TH1_Human | 1.44923390 |
| 43 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.44509460 |
| 44 | MYB_26560356_Chip-Seq_TH2_Human | 1.43792163 |
| 45 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.42501321 |
| 46 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.42477012 |
| 47 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.42367785 |
| 48 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.41624193 |
| 49 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.40711254 |
| 50 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.40427441 |
| 51 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.40350528 |
| 52 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.36652593 |
| 53 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.36434708 |
| 54 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.35537099 |
| 55 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.34466760 |
| 56 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.33355224 |
| 57 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.33342342 |
| 58 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.31702682 |
| 59 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.31702682 |
| 60 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.31584500 |
| 61 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.28532163 |
| 62 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.25787441 |
| 63 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.24893399 |
| 64 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.24596705 |
| 65 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.24405145 |
| 66 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.23312208 |
| 67 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.21833342 |
| 68 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.21609637 |
| 69 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.21088296 |
| 70 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.20622855 |
| 71 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.20138648 |
| 72 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.20121300 |
| 73 | ATF3_27146783_Chip-Seq_COLON_Human | 1.19543805 |
| 74 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.19215435 |
| 75 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.17773596 |
| 76 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.17460050 |
| 77 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.13379269 |
| 78 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11808886 |
| 79 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.10078771 |
| 80 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.09933581 |
| 81 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.09558736 |
| 82 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.09349872 |
| 83 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.08038191 |
| 84 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.07778376 |
| 85 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.05935938 |
| 86 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.05783326 |
| 87 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.03774023 |
| 88 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02915936 |
| 89 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.00025603 |
| 90 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.98806317 |
| 91 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.97164001 |
| 92 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.96533185 |
| 93 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.96154158 |
| 94 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96002154 |
| 95 | * HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.94864529 |
| 96 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.94224503 |
| 97 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.94118481 |
| 98 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.94006144 |
| 99 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.93000046 |
| 100 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.92900542 |
| 101 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.92462100 |
| 102 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92337585 |
| 103 | UTX_26944678_Chip-Seq_JUKART_Human | 0.91690597 |
| 104 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.91275264 |
| 105 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.90915356 |
| 106 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.90738882 |
| 107 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.90585577 |
| 108 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.90427128 |
| 109 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.89816567 |
| 110 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.89095222 |
| 111 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.89024221 |
| 112 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.88600382 |
| 113 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.88395859 |
| 114 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.86343070 |
| 115 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.85676398 |
| 116 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.85638972 |
| 117 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.83269515 |
| 118 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.83224347 |
| 119 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.82405576 |
| 120 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.82214727 |
| 121 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.82129576 |
| 122 | MYB_26560356_Chip-Seq_TH1_Human | 0.81551316 |
| 123 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.80337887 |
| 124 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.79689048 |
| 125 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.78886525 |
| 126 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.78846205 |
| 127 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.78443157 |
| 128 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.77333090 |
| 129 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.76871886 |
| 130 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.76483777 |
| 131 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.76114814 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 3.99434966 |
| 2 | MP0003303_peritoneal_inflammation | 3.64769768 |
| 3 | MP0004782_abnormal_surfactant_physiolog | 3.57862896 |
| 4 | MP0005360_urolithiasis | 3.25209572 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 3.24236024 |
| 6 | MP0005083_abnormal_biliary_tract | 3.10911073 |
| 7 | MP0005365_abnormal_bile_salt | 3.03406793 |
| 8 | MP0001666_abnormal_nutrient_absorption | 2.71968279 |
| 9 | MP0009840_abnormal_foam_cell | 2.40197174 |
| 10 | MP0005451_abnormal_body_composition | 2.37989329 |
| 11 | MP0008875_abnormal_xenobiotic_pharmacok | 2.26076362 |
| 12 | MP0003806_abnormal_nucleotide_metabolis | 2.25915870 |
| 13 | MP0010352_gastrointestinal_tract_polyps | 2.16666383 |
| 14 | MP0003252_abnormal_bile_duct | 2.11768289 |
| 15 | MP0010234_abnormal_vibrissa_follicle | 2.04563874 |
| 16 | MP0003705_abnormal_hypodermis_morpholog | 2.02507838 |
| 17 | MP0006082_CNS_inflammation | 1.91888957 |
| 18 | MP0006054_spinal_hemorrhage | 1.91719963 |
| 19 | MP0005387_immune_system_phenotype | 1.91217672 |
| 20 | MP0001790_abnormal_immune_system | 1.91217672 |
| 21 | MP0005000_abnormal_immune_tolerance | 1.86251426 |
| 22 | MP0003191_abnormal_cellular_cholesterol | 1.83581559 |
| 23 | MP0000685_abnormal_immune_system | 1.80279378 |
| 24 | MP0010329_abnormal_lipoprotein_level | 1.76868804 |
| 25 | MP0002148_abnormal_hypersensitivity_rea | 1.75300363 |
| 26 | MP0008057_abnormal_DNA_replication | 1.72765768 |
| 27 | MP0001800_abnormal_humoral_immune | 1.70559776 |
| 28 | MP0002138_abnormal_hepatobiliary_system | 1.69715774 |
| 29 | MP0008004_abnormal_stomach_pH | 1.67995821 |
| 30 | MP0004264_abnormal_extraembryonic_tissu | 1.65559826 |
| 31 | MP0003763_abnormal_thymus_physiology | 1.60810939 |
| 32 | MP0001958_emphysema | 1.58379755 |
| 33 | MP0002877_abnormal_melanocyte_morpholog | 1.57531439 |
| 34 | MP0002452_abnormal_antigen_presenting | 1.55067081 |
| 35 | MP0003724_increased_susceptibility_to | 1.50734069 |
| 36 | MP0002006_tumorigenesis | 1.50331939 |
| 37 | MP0002419_abnormal_innate_immunity | 1.49653743 |
| 38 | MP0009333_abnormal_splenocyte_physiolog | 1.49196996 |
| 39 | MP0002723_abnormal_immune_serum | 1.47822239 |
| 40 | MP0001853_heart_inflammation | 1.44046162 |
| 41 | MP0005671_abnormal_response_to | 1.42003870 |
| 42 | MP0003091_abnormal_cell_migration | 1.41686779 |
| 43 | MP0003186_abnormal_redox_activity | 1.35851633 |
| 44 | MP0008438_abnormal_cutaneous_collagen | 1.33515197 |
| 45 | MP0003693_abnormal_embryo_hatching | 1.32557097 |
| 46 | MP0005408_hypopigmentation | 1.30664438 |
| 47 | MP0005220_abnormal_exocrine_pancreas | 1.30470118 |
| 48 | MP0001819_abnormal_immune_cell | 1.28023998 |
| 49 | MP0002420_abnormal_adaptive_immunity | 1.27846233 |
| 50 | MP0000609_abnormal_liver_physiology | 1.26107822 |
| 51 | MP0004808_abnormal_hematopoietic_stem | 1.22349099 |
| 52 | MP0003436_decreased_susceptibility_to | 1.21089506 |
| 53 | MP0002398_abnormal_bone_marrow | 1.18862602 |
| 54 | MP0004185_abnormal_adipocyte_glucose | 1.18183966 |
| 55 | MP0003566_abnormal_cell_adhesion | 1.18070548 |
| 56 | MP0005023_abnormal_wound_healing | 1.17560012 |
| 57 | MP0003868_abnormal_feces_composition | 1.11461036 |
| 58 | MP0002118_abnormal_lipid_homeostasis | 1.10766143 |
| 59 | MP0005310_abnormal_salivary_gland | 1.10577857 |
| 60 | MP0003111_abnormal_nucleus_morphology | 1.09886162 |
| 61 | MP0000537_abnormal_urethra_morphology | 1.09023024 |
| 62 | MP0005275_abnormal_skin_tensile | 1.08907174 |
| 63 | MP0003950_abnormal_plasma_membrane | 1.08866452 |
| 64 | MP0000716_abnormal_immune_system | 1.08005331 |
| 65 | MP0009643_abnormal_urine_homeostasis | 1.06900084 |
| 66 | MP0010094_abnormal_chromosome_stability | 1.05188075 |
| 67 | MP0010307_abnormal_tumor_latency | 1.04516981 |
| 68 | MP0005332_abnormal_amino_acid | 1.04392780 |
| 69 | MP0002396_abnormal_hematopoietic_system | 1.03975899 |
| 70 | MP0004947_skin_inflammation | 1.03857294 |
| 71 | MP0003300_gastrointestinal_ulcer | 1.03383562 |
| 72 | MP0002009_preneoplasia | 1.02513377 |
| 73 | MP0004510_myositis | 1.02064547 |
| 74 | MP0002060_abnormal_skin_morphology | 1.01820710 |
| 75 | MP0003941_abnormal_skin_development | 1.00506269 |
| 76 | MP0000490_abnormal_crypts_of | 1.00491742 |
| 77 | MP0005319_abnormal_enzyme/_coenzyme | 0.99181605 |
| 78 | MP0005058_abnormal_lysosome_morphology | 0.98324042 |
| 79 | MP0002429_abnormal_blood_cell | 0.97203337 |
| 80 | MP0003656_abnormal_erythrocyte_physiolo | 0.97081964 |
| 81 | MP0002722_abnormal_immune_system | 0.97033251 |
| 82 | MP0000598_abnormal_liver_morphology | 0.94356282 |
| 83 | MP0000689_abnormal_spleen_morphology | 0.94156343 |
| 84 | MP0003221_abnormal_cardiomyocyte_apopto | 0.94054894 |
| 85 | MP0010155_abnormal_intestine_physiology | 0.93880946 |
| 86 | MP0005084_abnormal_gallbladder_morpholo | 0.93334752 |
| 87 | MP0002998_abnormal_bone_remodeling | 0.91542129 |
| 88 | MP0004019_abnormal_vitamin_homeostasis | 0.91321409 |
| 89 | MP0002098_abnormal_vibrissa_morphology | 0.90360361 |
| 90 | MP0008995_early_reproductive_senescence | 0.89946457 |
| 91 | MP0003453_abnormal_keratinocyte_physiol | 0.88243739 |
| 92 | MP0010368_abnormal_lymphatic_system | 0.88087021 |
| 93 | MP0003183_abnormal_peptide_metabolism | 0.86624043 |
| 94 | MP0003075_altered_response_to | 0.86403935 |
| 95 | MP0003077_abnormal_cell_cycle | 0.85989314 |
| 96 | MP0005076_abnormal_cell_differentiation | 0.85332887 |
| 97 | MP0002295_abnormal_pulmonary_circulatio | 0.85003688 |
| 98 | MP0009764_decreased_sensitivity_to | 0.84638450 |
| 99 | MP0003195_calcinosis | 0.84019753 |
| 100 | MP0005464_abnormal_platelet_physiology | 0.83471110 |
| 101 | MP0005621_abnormal_cell_physiology | 0.82780402 |
| 102 | MP0005397_hematopoietic_system_phenotyp | 0.82462671 |
| 103 | MP0001545_abnormal_hematopoietic_system | 0.82462671 |
| 104 | MP0002796_impaired_skin_barrier | 0.81639784 |
| 105 | MP0005166_decreased_susceptibility_to | 0.81570674 |
| 106 | MP0004957_abnormal_blastocyst_morpholog | 0.81258353 |
| 107 | MP0001873_stomach_inflammation | 0.81106624 |
| 108 | MP0005501_abnormal_skin_physiology | 0.80634455 |
| 109 | MP0001915_intracranial_hemorrhage | 0.80091673 |
| 110 | MP0009785_altered_susceptibility_to | 0.80061587 |
| 111 | MP0000566_synostosis | 0.80033114 |
| 112 | MP0001533_abnormal_skeleton_physiology | 0.79905491 |
| 113 | MP0009053_abnormal_anal_canal | 0.78890749 |
| 114 | MP0008469_abnormal_protein_level | 0.76651426 |
| 115 | MP0000858_altered_metastatic_potential | 0.74830642 |
| 116 | MP0002132_abnormal_respiratory_system | 0.74775425 |
| 117 | MP0010678_abnormal_skin_adnexa | 0.73948421 |
| 118 | MP0001243_abnormal_dermal_layer | 0.72833872 |
| 119 | MP0003943_abnormal_hepatobiliary_system | 0.72555410 |
| 120 | MP0009697_abnormal_copulation | 0.71330233 |
| 121 | MP0000627_abnormal_mammary_gland | 0.70951560 |
| 122 | MP0001835_abnormal_antigen_presentation | 0.69446311 |
| 123 | MP0005257_abnormal_intraocular_pressure | 0.69295543 |
| 124 | MP0001845_abnormal_inflammatory_respons | 0.69059028 |
| 125 | MP0001216_abnormal_epidermal_layer | 0.67914144 |
| 126 | MP0002133_abnormal_respiratory_system | 0.66693807 |
| 127 | MP0005388_respiratory_system_phenotype | 0.66693807 |
| 128 | MP0001177_atelectasis | 0.66333608 |
| 129 | MP0001881_abnormal_mammary_gland | 0.65271460 |
| 130 | MP0002254_reproductive_system_inflammat | 0.65197415 |
| 131 | MP0002166_altered_tumor_susceptibility | 0.65172288 |
| 132 | MP0009384_cardiac_valve_regurgitation | 0.64966967 |
| 133 | MP0002136_abnormal_kidney_physiology | 0.64468707 |
| 134 | MP0004272_abnormal_basement_membrane | 0.64351685 |
| 135 | MP0002405_respiratory_system_inflammati | 0.63988497 |
| 136 | MP0005164_abnormal_response_to | 0.63795670 |
| 137 | MP0000477_abnormal_intestine_morphology | 0.63441122 |
| 138 | MP0005636_abnormal_mineral_homeostasis | 0.62417497 |
| 139 | MP0009763_increased_sensitivity_to | 0.62416804 |
| 140 | MP0005647_abnormal_sex_gland | 0.62335335 |
| 141 | MP0002086_abnormal_extraembryonic_tissu | 0.62250022 |
| 142 | MP0001764_abnormal_homeostasis | 0.61491409 |
| 143 | MP0005025_abnormal_response_to | 0.61333264 |
| 144 | MP0003115_abnormal_respiratory_system | 0.60899643 |
| 145 | MP0003448_altered_tumor_morphology | 0.60700918 |
| 146 | MP0005248_abnormal_Harderian_gland | 0.59290746 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Interstitial pulmonary disease (HP:0006530) | 5.98115795 |
| 2 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.88136482 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 3.81220878 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 3.63798482 |
| 5 | Deep venous thrombosis (HP:0002625) | 3.41980950 |
| 6 | Xanthomatosis (HP:0000991) | 3.23682519 |
| 7 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.19815248 |
| 8 | Tubulointerstitial fibrosis (HP:0005576) | 3.19765827 |
| 9 | Gout (HP:0001997) | 3.16766939 |
| 10 | Abnormality of the intrinsic pathway (HP:0010989) | 3.09878552 |
| 11 | Fat malabsorption (HP:0002630) | 3.07646303 |
| 12 | Hypoglycemic coma (HP:0001325) | 3.05026643 |
| 13 | Recurrent viral infections (HP:0004429) | 3.03426040 |
| 14 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.02896079 |
| 15 | Abnormality of the common coagulation pathway (HP:0010990) | 2.94622258 |
| 16 | Eczematoid dermatitis (HP:0000976) | 2.93921060 |
| 17 | Systemic lupus erythematosus (HP:0002725) | 2.93309095 |
| 18 | Respiratory distress (HP:0002098) | 2.93305020 |
| 19 | Osteolytic defects of the hand bones (HP:0009699) | 2.87935119 |
| 20 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.87935119 |
| 21 | IgA deficiency (HP:0002720) | 2.77085913 |
| 22 | Esophageal varix (HP:0002040) | 2.71654492 |
| 23 | Autoimmune hemolytic anemia (HP:0001890) | 2.69971846 |
| 24 | Prolonged partial thromboplastin time (HP:0003645) | 2.68521221 |
| 25 | Hypolipoproteinemia (HP:0010981) | 2.68178359 |
| 26 | Recurrent bacterial skin infections (HP:0005406) | 2.60673125 |
| 27 | Gastrointestinal stroma tumor (HP:0100723) | 2.60641739 |
| 28 | Abnormality of purine metabolism (HP:0004352) | 2.59717007 |
| 29 | Abnormality of macrophages (HP:0004311) | 2.55675008 |
| 30 | Recurrent abscess formation (HP:0002722) | 2.55511604 |
| 31 | Micronodular cirrhosis (HP:0001413) | 2.53194814 |
| 32 | Hepatocellular carcinoma (HP:0001402) | 2.52428744 |
| 33 | Epidermoid cyst (HP:0200040) | 2.52329493 |
| 34 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.47958803 |
| 35 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.47958803 |
| 36 | Abnormality of glycolipid metabolism (HP:0010969) | 2.47958803 |
| 37 | Hydroxyprolinuria (HP:0003080) | 2.43195915 |
| 38 | Abnormality of proline metabolism (HP:0010907) | 2.43195915 |
| 39 | Abnormality of nucleobase metabolism (HP:0010932) | 2.39497770 |
| 40 | Myocardial infarction (HP:0001658) | 2.39408159 |
| 41 | Steatorrhea (HP:0002570) | 2.38543764 |
| 42 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.38115473 |
| 43 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.36568444 |
| 44 | Subacute progressive viral hepatitis (HP:0006572) | 2.35748428 |
| 45 | Polycythemia (HP:0001901) | 2.34697124 |
| 46 | Vasculitis (HP:0002633) | 2.34063346 |
| 47 | Ulnar bowing (HP:0003031) | 2.33891367 |
| 48 | Acanthocytosis (HP:0001927) | 2.32257707 |
| 49 | Chronic bronchitis (HP:0004469) | 2.27430706 |
| 50 | Colitis (HP:0002583) | 2.27119524 |
| 51 | Loss of speech (HP:0002371) | 2.26038537 |
| 52 | Abnormal cartilage morphology (HP:0002763) | 2.25919865 |
| 53 | Tachypnea (HP:0002789) | 2.23439184 |
| 54 | Orchitis (HP:0100796) | 2.22781785 |
| 55 | Retrobulbar optic neuritis (HP:0100654) | 2.22426417 |
| 56 | Optic neuritis (HP:0100653) | 2.22426417 |
| 57 | Chronic diarrhea (HP:0002028) | 2.19899759 |
| 58 | Joint hemorrhage (HP:0005261) | 2.17811190 |
| 59 | Hypoglycemic seizures (HP:0002173) | 2.17129529 |
| 60 | Mediastinal lymphadenopathy (HP:0100721) | 2.15174470 |
| 61 | Glomerulonephritis (HP:0000099) | 2.14162545 |
| 62 | Onycholysis (HP:0001806) | 2.13535283 |
| 63 | Conjugated hyperbilirubinemia (HP:0002908) | 2.12635815 |
| 64 | Autoimmune thrombocytopenia (HP:0001973) | 2.11561900 |
| 65 | Increased mean platelet volume (HP:0011877) | 2.09469148 |
| 66 | Hypoalphalipoproteinemia (HP:0003233) | 2.09201411 |
| 67 | Cellulitis (HP:0100658) | 2.08902816 |
| 68 | Hyperglycinuria (HP:0003108) | 2.08858734 |
| 69 | Ileus (HP:0002595) | 2.07858901 |
| 70 | Hyperlipoproteinemia (HP:0010980) | 2.05658460 |
| 71 | Vascular calcification (HP:0004934) | 2.04326964 |
| 72 | Cupped ribs (HP:0000887) | 2.03044510 |
| 73 | Tetraparesis (HP:0002273) | 2.02913607 |
| 74 | Increased IgM level (HP:0003496) | 2.02910709 |
| 75 | Fatigue (HP:0012378) | 2.01741340 |
| 76 | Pustule (HP:0200039) | 2.01546529 |
| 77 | T lymphocytopenia (HP:0005403) | 2.01050680 |
| 78 | Spastic diplegia (HP:0001264) | 2.00762685 |
| 79 | Complement deficiency (HP:0004431) | 1.99924317 |
| 80 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.99059296 |
| 81 | Abnormal biliary tract morphology (HP:0012440) | 1.99050086 |
| 82 | Recurrent bronchitis (HP:0002837) | 1.97524236 |
| 83 | Abnormality of the lumbar spine (HP:0100712) | 1.97107557 |
| 84 | Abnormality of T cell number (HP:0011839) | 1.97048733 |
| 85 | Cardiovascular calcification (HP:0011915) | 1.96907675 |
| 86 | Asymmetry of the thorax (HP:0001555) | 1.96889778 |
| 87 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.96700045 |
| 88 | Disinhibition (HP:0000734) | 1.96342685 |
| 89 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.92561271 |
| 90 | Hematochezia (HP:0002573) | 1.92172645 |
| 91 | Gangrene (HP:0100758) | 1.91872536 |
| 92 | Hyperammonemia (HP:0001987) | 1.91818227 |
| 93 | Rectal prolapse (HP:0002035) | 1.91599583 |
| 94 | Meningitis (HP:0001287) | 1.90871679 |
| 95 | Malnutrition (HP:0004395) | 1.90702823 |
| 96 | Abdominal distention (HP:0003270) | 1.90591073 |
| 97 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.90425951 |
| 98 | Emphysema (HP:0002097) | 1.90163671 |
| 99 | Tubulointerstitial abnormality (HP:0001969) | 1.89750303 |
| 100 | Beaking of vertebral bodies (HP:0004568) | 1.89610975 |
| 101 | Hyperactive renin-angiotensin system (HP:0000841) | 1.88929500 |
| 102 | Abnormality of complement system (HP:0005339) | 1.88875280 |
| 103 | Gingivitis (HP:0000230) | 1.88193796 |
| 104 | Keratoconjunctivitis sicca (HP:0001097) | 1.87944640 |
| 105 | Increased purine levels (HP:0004368) | 1.87904190 |
| 106 | Hyperuricemia (HP:0002149) | 1.87904190 |
| 107 | Lower limb hyperreflexia (HP:0002395) | 1.87784129 |
| 108 | Abnormal platelet volume (HP:0011876) | 1.87696671 |
| 109 | Hypercholesterolemia (HP:0003124) | 1.87505692 |
| 110 | Poikilocytosis (HP:0004447) | 1.87016641 |
| 111 | Orthostatic hypotension (HP:0001278) | 1.86776844 |
| 112 | Myositis (HP:0100614) | 1.85525976 |
| 113 | Thin bony cortex (HP:0002753) | 1.85407996 |
| 114 | Pulmonary infiltrates (HP:0002113) | 1.85309077 |
| 115 | Arterial thrombosis (HP:0004420) | 1.83845659 |
| 116 | Dysostosis multiplex (HP:0000943) | 1.83388800 |
| 117 | Hyperbilirubinemia (HP:0002904) | 1.82754810 |
| 118 | Tubulointerstitial nephritis (HP:0001970) | 1.82307816 |
| 119 | Hyperglycinemia (HP:0002154) | 1.81447738 |
| 120 | Bone pain (HP:0002653) | 1.81238201 |
| 121 | Progressive external ophthalmoplegia (HP:0000590) | 1.80792794 |
| 122 | Right ventricular cardiomyopathy (HP:0011663) | 1.80602847 |
| 123 | Hemorrhage of the eye (HP:0011885) | 1.79300465 |
| 124 | Cervical subluxation (HP:0003308) | 1.78751474 |
| 125 | B lymphocytopenia (HP:0010976) | 1.78686886 |
| 126 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.78403130 |
| 127 | Upper motor neuron abnormality (HP:0002127) | 1.78361675 |
| 128 | Osteomyelitis (HP:0002754) | 1.77553263 |
| 129 | Abnormality of glycine metabolism (HP:0010895) | 1.77399535 |
| 130 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.77399535 |
| 131 | Vacuolated lymphocytes (HP:0001922) | 1.76970903 |
| 132 | Increased serum ferritin (HP:0003281) | 1.76932048 |
| 133 | Hypergammaglobulinemia (HP:0010702) | 1.76157196 |
| 134 | Abnormality of methionine metabolism (HP:0010901) | 1.75418310 |
| 135 | Ankyloglossia (HP:0010296) | 1.73027368 |
| 136 | Glomerulosclerosis (HP:0000096) | 1.71561389 |
| 137 | Recurrent skin infections (HP:0001581) | 1.71453562 |
| 138 | Thoracolumbar scoliosis (HP:0002944) | 1.71268892 |
| 139 | Joint swelling (HP:0001386) | 1.71082063 |
| 140 | Increased IgE level (HP:0003212) | 1.70872354 |
| 141 | Tubular atrophy (HP:0000092) | 1.70578243 |
| 142 | Gingival bleeding (HP:0000225) | 1.70572117 |
| 143 | Symptomatic seizures (HP:0011145) | 1.70470459 |
| 144 | Viral hepatitis (HP:0006562) | 1.69805494 |
| 145 | Spontaneous hematomas (HP:0007420) | 1.69206372 |
| 146 | Abnormal foot bone ossification (HP:0010675) | 1.69179438 |
| 147 | Thrombophlebitis (HP:0004418) | 1.69151034 |
| 148 | Inflammation of the large intestine (HP:0002037) | 1.69006560 |
| 149 | Nausea (HP:0002018) | 1.68733730 |
| 150 | Mucosal telangiectasiae (HP:0100579) | 1.68653244 |
| 151 | Abnormality of the Achilles tendon (HP:0005109) | 1.67960335 |
| 152 | Abnormality of B cell number (HP:0010975) | 1.67678487 |
| 153 | Urticaria (HP:0001025) | 1.67355264 |
| 154 | Gastrointestinal inflammation (HP:0004386) | 1.67189277 |
| 155 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.66997058 |
| 156 | Abnormality of the renal cortex (HP:0011035) | 1.65689641 |
| 157 | Nephritis (HP:0000123) | 1.65682086 |
| 158 | IgM deficiency (HP:0002850) | 1.65350254 |
| 159 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.65070268 |
| 160 | Ridged nail (HP:0001807) | 1.64935370 |
| 161 | Vertebral compression fractures (HP:0002953) | 1.64849962 |
| 162 | Lymphoma (HP:0002665) | 1.64195502 |
| 163 | Flat acetabular roof (HP:0003180) | 1.64127885 |
| 164 | Gastrointestinal infarctions (HP:0005244) | 1.64068236 |
| 165 | Biliary tract neoplasm (HP:0100574) | 1.63346425 |
| 166 | Bowing of the arm (HP:0006488) | 1.63003696 |
| 167 | Bowed forearm bones (HP:0003956) | 1.63003696 |
| 168 | Periodontitis (HP:0000704) | 1.60483962 |
| 169 | Thrombocytosis (HP:0001894) | 1.59021943 |
| 170 | Abnormality of iron homeostasis (HP:0011031) | 1.57319653 |
| 171 | Nonimmune hydrops fetalis (HP:0001790) | 1.57085966 |
| 172 | Hyperglycemia (HP:0003074) | 1.55582926 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PRPF4B | 3.65299348 |
| 2 | FRK | 3.13494179 |
| 3 | EPHA2 | 3.05694053 |
| 4 | ERN1 | 2.85214407 |
| 5 | LATS1 | 2.64569413 |
| 6 | MST1R | 2.52387752 |
| 7 | MST4 | 2.02785238 |
| 8 | MAP3K3 | 2.01563466 |
| 9 | MAP3K13 | 1.96539560 |
| 10 | TAOK3 | 1.94654438 |
| 11 | SMG1 | 1.93971330 |
| 12 | STK3 | 1.85151449 |
| 13 | STK24 | 1.83737244 |
| 14 | BMPR2 | 1.80197972 |
| 15 | RIPK4 | 1.76936286 |
| 16 | TRIB3 | 1.73555258 |
| 17 | MAP2K2 | 1.68630171 |
| 18 | TAOK2 | 1.65174520 |
| 19 | RPS6KA4 | 1.62210489 |
| 20 | TESK1 | 1.62039298 |
| 21 | PTK6 | 1.60951451 |
| 22 | MET | 1.60900277 |
| 23 | FLT3 | 1.60328402 |
| 24 | LRRK2 | 1.58788264 |
| 25 | IRAK3 | 1.57878623 |
| 26 | BCKDK | 1.57741917 |
| 27 | PKN2 | 1.54027235 |
| 28 | STK10 | 1.49630129 |
| 29 | ZAP70 | 1.48799219 |
| 30 | NEK9 | 1.47682130 |
| 31 | CDK6 | 1.47639256 |
| 32 | NUAK1 | 1.45736532 |
| 33 | MAP4K1 | 1.35225535 |
| 34 | PAK4 | 1.35156292 |
| 35 | BRSK2 | 1.32399644 |
| 36 | PASK | 1.30793674 |
| 37 | FGFR4 | 1.28385075 |
| 38 | STK38L | 1.26066349 |
| 39 | NME2 | 1.25329897 |
| 40 | MAP3K14 | 1.23444956 |
| 41 | TBK1 | 1.19309141 |
| 42 | SIK1 | 1.15117630 |
| 43 | MOS | 1.14770422 |
| 44 | MAP2K3 | 1.14240644 |
| 45 | FGFR2 | 1.13570518 |
| 46 | EPHB1 | 1.13319894 |
| 47 | JAK3 | 1.13230687 |
| 48 | MATK | 1.09735445 |
| 49 | EIF2AK3 | 1.06867004 |
| 50 | RPS6KB2 | 1.04671122 |
| 51 | BLK | 1.04252179 |
| 52 | CHUK | 1.03367456 |
| 53 | WEE1 | 1.02497730 |
| 54 | TYK2 | 1.02060647 |
| 55 | TGFBR2 | 1.00283561 |
| 56 | RIPK1 | 1.00260736 |
| 57 | NEK2 | 0.98930002 |
| 58 | CLK1 | 0.97484780 |
| 59 | PIK3CG | 0.96501126 |
| 60 | MAP3K2 | 0.95624586 |
| 61 | TGFBR1 | 0.95513053 |
| 62 | MAPK11 | 0.94869127 |
| 63 | EPHA3 | 0.94507154 |
| 64 | PBK | 0.93541521 |
| 65 | ICK | 0.92031212 |
| 66 | DDR2 | 0.90958455 |
| 67 | MAP3K8 | 0.90176700 |
| 68 | MELK | 0.89963834 |
| 69 | ACVR1B | 0.89948937 |
| 70 | INSRR | 0.88509774 |
| 71 | PIM1 | 0.88389679 |
| 72 | STK4 | 0.87980727 |
| 73 | LATS2 | 0.87685841 |
| 74 | TRPM7 | 0.83959994 |
| 75 | KSR2 | 0.82550679 |
| 76 | PIM2 | 0.82104620 |
| 77 | PRKG2 | 0.82100110 |
| 78 | DYRK1B | 0.80223680 |
| 79 | BMX | 0.78873264 |
| 80 | PTK2 | 0.78198591 |
| 81 | EEF2K | 0.74556086 |
| 82 | PDGFRB | 0.74133769 |
| 83 | AURKB | 0.73835131 |
| 84 | BRD4 | 0.73314319 |
| 85 | JAK2 | 0.72202404 |
| 86 | MAPK15 | 0.71540338 |
| 87 | CSF1R | 0.71247944 |
| 88 | SCYL2 | 0.71068517 |
| 89 | ERBB4 | 0.70545469 |
| 90 | EIF2AK1 | 0.69902334 |
| 91 | CDC42BPA | 0.69616868 |
| 92 | FGR | 0.68794478 |
| 93 | GRK7 | 0.67563800 |
| 94 | NEK1 | 0.65604464 |
| 95 | PDGFRA | 0.65327706 |
| 96 | MAP3K1 | 0.65009935 |
| 97 | PDK2 | 0.64374315 |
| 98 | FGFR3 | 0.64182378 |
| 99 | EIF2AK2 | 0.62808434 |
| 100 | IKBKB | 0.62507151 |
| 101 | PLK4 | 0.61884844 |
| 102 | CDC7 | 0.61289590 |
| 103 | GSK3A | 0.61221953 |
| 104 | MAP3K10 | 0.60458236 |
| 105 | TEC | 0.59672572 |
| 106 | IKBKE | 0.59400039 |
| 107 | ARAF | 0.59352230 |
| 108 | ZAK | 0.58408436 |
| 109 | FER | 0.58407355 |
| 110 | IRAK2 | 0.58334049 |
| 111 | CDK4 | 0.57807865 |
| 112 | TTK | 0.56964056 |
| 113 | CSK | 0.56948077 |
| 114 | ABL2 | 0.56418624 |
| 115 | IRAK1 | 0.55402831 |
| 116 | MTOR | 0.54823592 |
| 117 | CDK12 | 0.51541424 |
| 118 | TIE1 | 0.50785226 |
| 119 | YES1 | 0.50604804 |
| 120 | SRPK1 | 0.50432579 |
| 121 | DYRK3 | 0.50398856 |
| 122 | TESK2 | 0.49967343 |
| 123 | MAP2K1 | 0.47671119 |
| 124 | MAPKAPK3 | 0.47269572 |
| 125 | ERBB2 | 0.47026501 |
| 126 | MAP3K5 | 0.46837852 |
| 127 | BTK | 0.46440983 |
| 128 | SIK3 | 0.45761810 |
| 129 | ALK | 0.45232695 |
| 130 | TTN | 0.43958755 |
| 131 | IRAK4 | 0.43763166 |
| 132 | MAP3K9 | 0.43282610 |
| 133 | BRAF | 0.42160278 |
| 134 | PAK2 | 0.41105264 |
| 135 | SYK | 0.40387043 |
| 136 | CDK7 | 0.39972213 |
| 137 | CAMK1D | 0.38804759 |
| 138 | BUB1 | 0.38779624 |
| 139 | JAK1 | 0.38038040 |
| 140 | LYN | 0.38013311 |
| 141 | EGFR | 0.37913569 |
| 142 | PDPK1 | 0.36627362 |
| 143 | TAF1 | 0.34361808 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.64520423 |
| 2 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.47140926 |
| 3 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.46738099 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.35616919 |
| 5 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.18588875 |
| 6 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.00709668 |
| 7 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.00524993 |
| 8 | Allograft rejection_Homo sapiens_hsa05330 | 1.98111512 |
| 9 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.93852838 |
| 10 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.90261837 |
| 11 | Measles_Homo sapiens_hsa05162 | 1.88186179 |
| 12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.87732201 |
| 13 | Histidine metabolism_Homo sapiens_hsa00340 | 1.79866700 |
| 14 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.77680838 |
| 15 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.74679855 |
| 16 | Other glycan degradation_Homo sapiens_hsa00511 | 1.74496252 |
| 17 | Asthma_Homo sapiens_hsa05310 | 1.72281966 |
| 18 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.69090543 |
| 19 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.68665129 |
| 20 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.67769472 |
| 21 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.67396096 |
| 22 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.67145187 |
| 23 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.65181122 |
| 24 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.60795877 |
| 25 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.58536380 |
| 26 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.58453374 |
| 27 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.53610011 |
| 28 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.50803452 |
| 29 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.50439454 |
| 30 | Hepatitis B_Homo sapiens_hsa05161 | 1.48847243 |
| 31 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.48667964 |
| 32 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.46611985 |
| 33 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.43930603 |
| 34 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.36469284 |
| 35 | Peroxisome_Homo sapiens_hsa04146 | 1.35763868 |
| 36 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.34189441 |
| 37 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.32380872 |
| 38 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.31389925 |
| 39 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.31370918 |
| 40 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.29557548 |
| 41 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.27994599 |
| 42 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.27481732 |
| 43 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.26535470 |
| 44 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.24283443 |
| 45 | Mineral absorption_Homo sapiens_hsa04978 | 1.24227893 |
| 46 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.23744655 |
| 47 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.21479090 |
| 48 | Retinol metabolism_Homo sapiens_hsa00830 | 1.20802187 |
| 49 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.20475646 |
| 50 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.19259045 |
| 51 | Tuberculosis_Homo sapiens_hsa05152 | 1.17789232 |
| 52 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.16606809 |
| 53 | Legionellosis_Homo sapiens_hsa05134 | 1.16040814 |
| 54 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.13769855 |
| 55 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.10419541 |
| 56 | ABC transporters_Homo sapiens_hsa02010 | 1.09357272 |
| 57 | Protein export_Homo sapiens_hsa03060 | 1.09319473 |
| 58 | Viral myocarditis_Homo sapiens_hsa05416 | 1.09227753 |
| 59 | Prion diseases_Homo sapiens_hsa05020 | 1.09043513 |
| 60 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.08567026 |
| 61 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.07590925 |
| 62 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.06885888 |
| 63 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.06508362 |
| 64 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.03432817 |
| 65 | Shigellosis_Homo sapiens_hsa05131 | 1.03129122 |
| 66 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.02065743 |
| 67 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.99244839 |
| 68 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.95706570 |
| 69 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.92261890 |
| 70 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.91816329 |
| 71 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.91712138 |
| 72 | Salmonella infection_Homo sapiens_hsa05132 | 0.91145785 |
| 73 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.89737986 |
| 74 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.88945134 |
| 75 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.88697373 |
| 76 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.87705409 |
| 77 | Galactose metabolism_Homo sapiens_hsa00052 | 0.85330407 |
| 78 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.84104293 |
| 79 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.83860367 |
| 80 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.83732639 |
| 81 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.83545002 |
| 82 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.83151043 |
| 83 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.80487545 |
| 84 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.80316519 |
| 85 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.79959944 |
| 86 | Bile secretion_Homo sapiens_hsa04976 | 0.79291418 |
| 87 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.78808934 |
| 88 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.77934366 |
| 89 | Sulfur relay system_Homo sapiens_hsa04122 | 0.77279498 |
| 90 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.76587030 |
| 91 | HTLV-I infection_Homo sapiens_hsa05166 | 0.74165321 |
| 92 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.73418929 |
| 93 | Cell cycle_Homo sapiens_hsa04110 | 0.72288928 |
| 94 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.72090224 |
| 95 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.70957458 |
| 96 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.70186591 |
| 97 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.68378237 |
| 98 | Carbon metabolism_Homo sapiens_hsa01200 | 0.67959718 |
| 99 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.67592879 |
| 100 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.67252889 |
| 101 | Prostate cancer_Homo sapiens_hsa05215 | 0.66783482 |
| 102 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.65404721 |
| 103 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.65399678 |
| 104 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.65186279 |
| 105 | Bladder cancer_Homo sapiens_hsa05219 | 0.64515837 |
| 106 | Malaria_Homo sapiens_hsa05144 | 0.63780606 |
| 107 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.63580748 |
| 108 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.63235152 |
| 109 | Apoptosis_Homo sapiens_hsa04210 | 0.60248305 |
| 110 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.60169963 |
| 111 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.59667992 |
| 112 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.59380828 |
| 113 | Influenza A_Homo sapiens_hsa05164 | 0.59231848 |
| 114 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.59172418 |
| 115 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.58779935 |
| 116 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.58646726 |
| 117 | Lysosome_Homo sapiens_hsa04142 | 0.58640377 |
| 118 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.58490973 |
| 119 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.58278364 |
| 120 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.57313916 |
| 121 | DNA replication_Homo sapiens_hsa03030 | 0.57190022 |
| 122 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.56569719 |
| 123 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.56040337 |
| 124 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.55734399 |
| 125 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.55689575 |
| 126 | Leishmaniasis_Homo sapiens_hsa05140 | 0.54993663 |
| 127 | Adherens junction_Homo sapiens_hsa04520 | 0.54518034 |
| 128 | Pertussis_Homo sapiens_hsa05133 | 0.52435111 |
| 129 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.52250819 |
| 130 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.51967848 |
| 131 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.51347463 |
| 132 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.50897383 |
| 133 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.49182860 |
| 134 | Hepatitis C_Homo sapiens_hsa05160 | 0.48631050 |
| 135 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.48137468 |
| 136 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.47424389 |
| 137 | Thyroid cancer_Homo sapiens_hsa05216 | 0.47288333 |
| 138 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.47063670 |
| 139 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.46502810 |
| 140 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.46259564 |
| 141 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.45932656 |
| 142 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.45886050 |
| 143 | Lysine degradation_Homo sapiens_hsa00310 | 0.45650345 |
| 144 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.44630718 |
| 145 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.43922031 |
| 146 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.42104050 |
| 147 | Insulin resistance_Homo sapiens_hsa04931 | 0.41719861 |
| 148 | Amoebiasis_Homo sapiens_hsa05146 | 0.40089246 |
| 149 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.39525009 |
| 150 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.38890706 |

